Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial. [electronic resource]
Producer: 20100806Description: 672-80 p. digitalISSN:- 1474-4465
- Adjuvants, Immunologic -- therapeutic use
- Adult
- Disability Evaluation
- Double-Blind Method
- Drug Therapy, Combination -- methods
- Female
- Humans
- Interferon beta-1a
- Interferon-beta -- therapeutic use
- Kaplan-Meier Estimate
- Longitudinal Studies
- Male
- Methylprednisolone -- therapeutic use
- Middle Aged
- Multiple Sclerosis, Relapsing-Remitting -- drug therapy
- Neuroprotective Agents -- therapeutic use
- Severity of Illness Index
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.